Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbook

Urinalysis, bladder diary, flow rate and residual volume

Choose and interpret complementary urinary tests, recognise measurement limitations and connect results to an appropriate clinical decision.

Saved on this device
Open the sections you need. The overview is shown first.
01Principles and purposeThe professional or clinical skill and the decisions it supports.

These tests answer related but different questions. Urinalysis looks for chemical or inflammatory clues. A diary measures the pattern experienced outside the clinic. Uroflowmetry records how quickly urine leaves the bladder, while a residual measurement describes how much remains. Putting their results together can distinguish excess production from limited storage and raise or lower suspicion of ineffective emptying. Combining imperfect tests does not eliminate their limitations, so the clinician must still connect findings to the original complaint.

Quality begins before the result appears. A hurried void into a flowmeter when the patient has little urge, a diary completed from memory or a scan delayed while more urine enters the bladder can generate a precise-looking but misleading number. Record the circumstances, ask whether voiding was typical and repeat discordant measurements when the clinical situation allows. Acute painful retention, sepsis or evidence of upper tract compromise requires action rather than repeated testing for an ideal dataset.

Key points

  • A urine result is meaningful only when collection quality, symptoms and the patient’s population are specified.
  • A bladder diary records intake, voided volumes, timing, urgency and leakage over representative daily activities.
  • Nocturnal urine production includes the first morning void; the last void before sleep is excluded.
  • Low maximum flow can reflect obstruction, detrusor underactivity or an inadequately filled bladder.
  • Measure residual promptly after a representative void, and interpret unexpected values with repeat assessment when safe.
  • Selected pressure-flow studies distinguish high-pressure low flow from detrusor weakness; a free-flow trace or residual alone cannot establish that mechanism.
02Situations and prioritiesThe context, relevant information and actions that matter most.
Production versus storage

Frequent 400 ml voids and frequent 60 ml voids represent different physiological problems. Ask about thirst, fluid intake and diuretics, then calculate total output. A normal daily total with frequent small voids suggests limited functional capacity or habitual early voiding.

A representative flow trace

Interpret maximum flow alongside the full curve, voided volume and the patient’s account. A broad low curve can raise suspicion of obstruction, but it also occurs with poor contraction. An interrupted trace may reflect straining or intermittent sphincter relaxation.

Potentially misleading residual

Ascites, cystic pelvic structures, obesity or poor positioning may confuse automated bladder scanners. A result grossly inconsistent with examination or catheter drainage should prompt verification of technique or formal imaging rather than unquestioning acceptance.

Findings requiring action

Visible blood, recurrent symptomatic infection, retention and declining renal function require targeted follow-through. New urgency accompanied by glycosuria and large daily output is not adequately assessed by ordering an outlet procedure from a low flow measurement.

03Assessment and interpretationHow to gather information, assess the situation and recognise uncertainty.
Reasoning sequence

Consider the information, its meaning and its limitations before deciding what follows.

  1. 01
    Urine dipstick and specimen quality
    Why
    Screen for blood, protein, glucose and inflammatory markers using a fresh appropriate sample.
    Interpretation and limitations
    Document timing, symptoms and recent instrumentation. Collect midstream urine when culture is indicated; take a catheter specimen aseptically from the sampling port rather than the drainage bag. Colonisation of a catheter does not by itself establish symptomatic infection.
  2. 02
    Three-day frequency-volume diary
    Why
    Quantify daily output and identify the relation between voiding, sleep and symptoms.
    Interpretation and limitations
    Include normal working and leisure activities rather than an artificially restricted drinking day. Add total measured volumes across each 24-hour period. The night-time fraction includes the first morning urine because it was produced during sleep; define sleep times before calculating it.
  3. 03
    Free uroflowmetry
    Why
    Measure voided volume, maximum flow and curve shape in an uninstrumented void.
    Interpretation and limitations
    A volume above approximately 150 ml improves interpretability in adult men. Repeat a low-volume or unrepresentative test. A maximum flow below 10 ml/s raises suspicion but cannot distinguish high-resistance obstruction from weak detrusor contraction without additional information.
  4. 04
    Post-void residual measurement
    Why
    Estimate emptying efficiency immediately after the relevant void.
    Interpretation and limitations
    Use a bladder scan where suitable and record delay and voided volume. Residual 150 ml after voiding 50 ml differs from the same residual after voiding 600 ml. No universal PVR cut-off determines treatment in all adults; risk, trend and symptoms matter.
  5. 05
    Pressure-flow studies when selected
    Why
    Separate detrusor pressure from outlet resistance when this would change an invasive treatment decision.
    Interpretation and limitations
    High pressure with low flow supports obstruction; low pressure with low flow supports poor contraction. The study has its own technical and patient-related limitations. It is not a routine confirmation test after every mildly abnormal free flow.
04Worked approachesCases with ordered reasoning, an action and a check of the outcome.
01Worked caseAn unrepresentative first flowA 69-year-old man is referred after one low-volume clinic flow test.
  1. 1He reports bothersome nocturia but little daytime difficulty. His first test gives maximum flow 7 ml/s with only 65 ml voided; PVR is 25 ml and the void felt unusually small.
  2. 2A three-day diary shows 2,100 ml total daily output, including 900 ml overnight with the first morning void, and usual daytime voids around 300 ml. The nocturnal fraction is about 43%, suggesting a production contribution.
  3. 3Repeat testing at a comfortable urge gives a 310 ml void, maximum flow 18 ml/s and PVR 30 ml. The first low flow was insufficient evidence for fixed outlet obstruction.
  4. 4After checking evening intake, oedema and sleep symptoms, the clinician and patient agree to move discretionary evening drinks earlier and replace evening caffeine with non-caffeinated drinks, maintaining appropriate daytime hydration. He implements these changes; six weeks later he reports one fewer nightly waking without a change in daytime stream.
  5. 5Verification includes a repeat representative diary, the patient’s sleep benefit and continuing absence of retention or renal red flags. The improvement does not establish that every cause of nocturia has been eliminated.
02Discordant resultsCheck the measurement before the conclusionSymptoms, scan findings and observed urine volumes do not agree.
  1. 1Repeat the history of what happened during the test, check units and identify whether the scanner measured a pre-void or post-void bladder. Confirm whether a delay or additional drink changed the result.
  2. 2If clinically safe, repeat the void and scan under better conditions. Persistent discrepancy, a pelvic mass or ascites may require formal ultrasound or an alternative method rather than averaging implausible readings.
  3. 3Escalate a reproducibly large residual with infection, hydronephrosis or renal dysfunction. In stable lower-risk incomplete emptying, integrate the trend with symptoms and likely detrusor function before deciding on intervention.
03Urine abnormalityFollow a clue to its causeUrinalysis identifies a finding that the presenting label does not explain.
  1. 1For dysuria and systemic symptoms, assess infection severity and obtain an appropriate culture before treatment when feasible. Do not use a bag specimen to choose long-term antibiotics in a catheterised patient.
  2. 2For blood, establish whether it is visible, persistent or associated with instrumentation or infection and arrange the appropriate reassessment or referral. A previous BPE diagnosis is not an explanation by default.
  3. 3For glycosuria with substantial measured urine production, assess blood glucose and metabolic symptoms. For protein and blood with AKI, consider intrinsic renal disease as well as obstruction, using the examination and renal pathway.
05Feedback, follow-up and evidenceReview outcomes, seek feedback and identify what to improve.
  • Store voided volume, flow shape, maximum flow and residual together so later clinicians can compare like with like instead of following isolated peak numbers.
  • Ask the patient to mark changes in medicine timing or activity on repeat diaries; this allows an apparent treatment effect to be distinguished from changed behaviour.
  • Recheck significant abnormalities after reversible contributors such as infection or severe constipation improve, while maintaining a drainage plan when renal safety depends on it.
  • Audit whether each investigation changed a decision: a test with an unanswered indication may create incidental findings without helping the patient’s actual symptom goal.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Calculate emptying efficiency

For a voided volume of 300 ml and residual of 100 ml, observed voiding efficiency is 300 divided by 400, or 75%. This contextualises residual volume but does not identify its pressure mechanism.

Diary completion support

Poor literacy, dexterity or access to a measuring jug may undermine recording. Demonstrate one entry, adapt the format and involve a willing carer rather than classifying the person as non-adherent.

Different guideline settings

NICE CG97 does not routinely request flow and residual at initial nonspecialist male assessment, while EAU recommends broader assessment. State the setting when teaching an investigation priority to avoid a false contradiction.

Women with emptying symptoms

NICE NG123 supports residual assessment in women with voiding dysfunction or recurrent UTI and favours bladder scanning. Male prostate-volume or uroflow thresholds should not be transferred as universal female diagnostic rules.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Do not diagnose bladder outlet obstruction from a maximum flow measured after a tiny void; repeatability and bladder filling are essential context.

  2. 02

    Avoid treating a single residual number as an automatic catheterisation threshold in every patient, particularly when renal risk and the trend are unknown.

  3. 03

    A night-time volume calculation that omits the first morning void underestimates nocturnal production and may misclassify the reason for repeated waking.

  4. 04

    Do not mistake asymptomatic catheter bacteriuria for infection or send a stagnant drainage-bag sample as if it represented a fresh sterile specimen.

Practice

Two practice questions

Question 1 of 20 correct
UrologyOriginal SBA

Reading the diary

A 70-year-old man’s representative diary records 2,000 ml in 24 hours. Night-time voids plus the first morning void total 900 ml, while individual daytime voids are usually 300–350 ml. What is the most useful interpretation?

Sources and review status8 sources · checked 8 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 8 Sept 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom